RICHARD BEALS: Open Payments
NPI 1669884847 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,733 in 113 payments from 17 companies in 2025. Trend: 2023 $1,962 · 2024 $2,405 · 2025 $1,733
Food & beverage: $1,733
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $243 |
| ABBVIE INC. | 22 | $242 |
| Corium, LLC | 13 | $239 |
| Tris Pharma Inc | 19 | $224 |
| Axsome Therapeutics, Inc. | 11 | $204 |
| Lundbeck LLC | 8 | $167 |
| Collegium Pharmaceutical, Inc. | 8 | $150 |
| Supernus Pharmaceuticals, Inc. | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Vertical Pharmaceuticals, LLC | 1 | $25 |
Products named: REXULTI, VRAYLAR, Azstarys, Dyanavel XR, Auvelity, Jornay PM, Qelbree, ABILIFY MAINTENA.
Industry payments across AZ — which companies pay providers there.
